126 related articles for article (PubMed ID: 8738213)
1. Double-site ricin B chain mutants retain galactose binding.
Frankel A; Tagge E; Chandler J; Burbage C; Willingham M
Protein Eng; 1996 Apr; 9(4):371-9. PubMed ID: 8738213
[TBL] [Abstract][Full Text] [Related]
2. Ricin toxin contains at least three galactose-binding sites located in B chain subdomains 1 alpha, 1 beta, and 2 gamma.
Frankel AE; Burbage C; Fu T; Tagge E; Chandler J; Willingham MC
Biochemistry; 1996 Nov; 35(47):14749-56. PubMed ID: 8942636
[TBL] [Abstract][Full Text] [Related]
3. Double-lectin site ricin B chain mutants expressed in insect cells have residual galactose binding: evidence for more than two lectin sites on the ricin toxin B chain.
Fu T; Burbage C; Tagge E; Chandler J; Willingham M; Frankel A
Bioconjug Chem; 1996; 7(6):651-8. PubMed ID: 8950484
[TBL] [Abstract][Full Text] [Related]
4. Expression of oligohistidine-tagged ricin B chain in Spodoptera frugiperda.
Afrin LB; Gulick H; Vesely J; Willingham M; Frankel AE
Bioconjug Chem; 1994; 5(6):539-46. PubMed ID: 7533004
[TBL] [Abstract][Full Text] [Related]
5. Characterization of single site ricin toxin B chain mutants.
Frankel A; Tagge E; Chandler J; Burbage C; Hancock G; Vesely J; Willingham M
Bioconjug Chem; 1996; 7(1):30-7. PubMed ID: 8741988
[TBL] [Abstract][Full Text] [Related]
6. Ricin fusion toxin targeted to the human granulocyte-macrophage colony stimulating factor receptor is selectively toxic to acute myeloid leukemia cells.
Burbage C; Tagge EP; Harris B; Hall P; Fu T; Willingham MC; Frankel AE
Leuk Res; 1997 Jul; 21(7):681-90. PubMed ID: 9301690
[TBL] [Abstract][Full Text] [Related]
7. IL2-ricin fusion toxin is selectively cytotoxic in vitro to IL2 receptor-bearing tumor cells.
Frankel A; Tagge E; Chandler J; Burbage C; Hancock G; Vesely J; Willingham M
Bioconjug Chem; 1995; 6(6):666-72. PubMed ID: 8608178
[TBL] [Abstract][Full Text] [Related]
8. Preproricin expressed in Nicotiana tabacum cells in vitro is fully processed and biologically active.
Tagge EP; Chandler J; Harris B; Czako M; Marton L; Willingham MC; Burbage C; Afrin L; Frankel AE
Protein Expr Purif; 1996 Aug; 8(1):109-18. PubMed ID: 8812841
[TBL] [Abstract][Full Text] [Related]
9. Expression and secretion of a recombinant ricin immunotoxin from murine myeloma cells.
Krek CE; Ladino CA; Goldmacher VS; Blättler WA; Guild BC
Protein Eng; 1995 May; 8(5):481-9. PubMed ID: 8532670
[TBL] [Abstract][Full Text] [Related]
10. Characterization of a ricin fusion toxin targeted to the interleukin-2 receptor.
Frankel AE; Burbage C; Fu T; Tagge E; Chandler J; Willingham M
Protein Eng; 1996 Oct; 9(10):913-9. PubMed ID: 8931131
[TBL] [Abstract][Full Text] [Related]
11. IL2 fused to lectin-deficient ricin is toxic to human leukemia cells expressing the IL2 receptor.
Frankel AE; Fu T; Burbage C; Chandler J; Willingham MC; Tagge EP
Leukemia; 1997 Jan; 11(1):22-30. PubMed ID: 9001414
[TBL] [Abstract][Full Text] [Related]
12. Mutational analysis of the galactose binding ability of recombinant ricin B chain.
Wales R; Richardson PT; Roberts LM; Woodland HR; Lord JM
J Biol Chem; 1991 Oct; 266(29):19172-9. PubMed ID: 1717462
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the Asialofetuin microtitre plate-binding assay for evaluating inhibitors of ricin lectin activity.
Dawson RM; Paddle BM; Alderton MR
J Appl Toxicol; 1999; 19(5):307-12. PubMed ID: 10513675
[TBL] [Abstract][Full Text] [Related]
14. Cell surface and intracellular functions for ricin galactose binding.
Newton DL; Wales R; Richardson PT; Walbridge S; Saxena SK; Ackerman EJ; Roberts LM; Lord JM; Youle RJ
J Biol Chem; 1992 Jun; 267(17):11917-22. PubMed ID: 1601861
[TBL] [Abstract][Full Text] [Related]
15. Expression of ricin B chain in Spodoptera frugiperda.
Frankel A; Roberts H; Gulick H; Afrin L; Vesely J; Willingham M
Biochem J; 1994 Nov; 303 ( Pt 3)(Pt 3):787-94. PubMed ID: 7980448
[TBL] [Abstract][Full Text] [Related]
16. Phage display of ricin B chain and its single binding domains: system for screening galactose-binding mutants.
Swimmer C; Lehar SM; McCafferty J; Chiswell DJ; Blättler WA; Guild BC
Proc Natl Acad Sci U S A; 1992 May; 89(9):3756-60. PubMed ID: 1373889
[TBL] [Abstract][Full Text] [Related]
17. Expression and functional properties of genetically engineered ricin B chain lacking galactose-binding activity.
Vitetta ES; Yen N
Biochim Biophys Acta; 1990 Jun; 1049(2):151-7. PubMed ID: 1694694
[TBL] [Abstract][Full Text] [Related]
18. The effects of N-glycosylation on the lectin activity of recombinant ricin B chain.
Richardson PT; Hussain K; Woodland HR; Lord JM; Roberts LM
Carbohydr Res; 1991 Jun; 213():19-25. PubMed ID: 1718601
[TBL] [Abstract][Full Text] [Related]
19. Ricin toxin contains three lectin sites which contribute to its in vivo toxicity.
Fu T; Burbage C; Tagge EP; Brothers T; Willingham MC; Frankel AE
Int J Immunopharmacol; 1996 Dec; 18(12):685-92. PubMed ID: 9172011
[TBL] [Abstract][Full Text] [Related]
20. Ricin B chain fragments expressed in Escherichia coli are able to bind free galactose in contrast to the full length polypeptide.
Wales R; Gorham HC; Hussain K; Roberts LM; Lord JM
Glycoconj J; 1994 Aug; 11(4):274-81. PubMed ID: 7873921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
